Výsledky vyhledávání - "Michael Conner"

Akademický článek

Emergence of the CD226 Axis in Cancer Immunotherapy

Autor: Michael Conner, Ken W. Hance, Sapna Yadavilli, James Smothers, Jeremy D. Waight

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

In recent years, a set of immune receptors that interact with members of the nectin/nectin-like (necl) family has garnered significant attention as possible points of manipulation in cancer. Central to this axis, CD226, TIGIT, and CD96 represent liga

Externí odkaz: https://doaj.org/article/de4cbba0e3fd4f49b752e681262c16cf

Zobrazit plný text záznamu

Akademický článek

Congenital presentation of synchronous Atypical Teratoid Rhabdoid Tumor and Malignant Rhabdoid Tumor of the urinary bladder in a term infant

Autor: Vivian Tang, Peter Michael Conner, Jason Paul Tovar, Regina Frances Gandour-Edwards, Reuben Antony, Matthew Bobinsk, Michael Steven Brent Edwards, Mirna Lechpamme

Publikováno v: Autopsy and Case Reports, Vol 10, Iss 4 (2021)

Atypical teratoid/rhabdoid tumor (AT/RT) is a rare central nervous system (CNS) tumor diagnosed primarily in infants and usually portends a poor prognosis. Despite being the most common embryonal tumor in children less than 1 year old, diagnosis is d

Externí odkaz: https://doaj.org/article/b17f088a19534822b886dc96f0e9dee4

Zobrazit plný text záznamu

Akademický článek

Feasibility of Utilizing PREMM Score for Lynch Syndrome Identification in an Urban, Minority Patient Population

Autor: Brigid Adviento, Michael Conner, Alexander Sarkisian, Nicolette Walano, Hans Andersson, Jordan Karlitz

Publikováno v: Journal of Primary Care & Community Health, Vol 12 (2021)

The PREMM 5 model is a web-based clinical prediction algorithm that estimates the gene-specific risk of an individual carrying a Lynch syndrome germline mutation based on targeted family history questions. The objectives of our study were to determin

Externí odkaz: https://doaj.org/article/2d8f06f5fe0b490f8bf7d3207d6051ea

Zobrazit plný text záznamu

Supplementary Figure 4 from Effect of Niclosamide on Basal-like Breast Cancers

Autor: Donald J. Buchsbaum, Yonghe Li, Albert F. LoBuglio, Andres Forero-Torres, Michael Conner, William E. Grizzle, Bertha Hidalgo, Brandon J. Metge, Rajeev S. Samant, Wenyan Lu, Laura Aristizabal, Rebecca C. Arend, Angelina I. Londoño-Joshi

PDF file - 96KB, Supplementary Figure S4. Wnt/beta-catenin signaling proteins in LRP6 KD cells. Western blot for expression of Wnt/beta-catenin signaling proteins in adherent 2LMP shRNA LRP6 knockdown cells compared to shRNA control cells.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62391a1fdd262bc11149ca51aa330ba1
https://doi.org/10.1158/1535-7163.22501198.v1

Zobrazit plný text záznamu

Data from Effect of Niclosamide on Basal-like Breast Cancers

Basal-like breast cancers (BLBC) are poorly differentiated and display aggressive clinical behavior. These tumors become resistant to cytotoxic agents, and tumor relapse has been attributed to the presence of cancer stem cells (CSC). One of the pathw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b9fc754454330c6f71df77c99c1a53c4
https://doi.org/10.1158/1535-7163.c.6536704.v1

Zobrazit plný text záznamu

Supplementary Figure 1 from Effect of Niclosamide on Basal-like Breast Cancers

PDF file - 128KB, Supplementary Figure S1. Sensitivity of MF10A mammary epithelial cells to niclosamide and TRA-8 mediated cytotoxicity. (A) Attached MCF10A cell line was treated for 48 hours with niclosamide (0.08, 0.1, 0.25 and 0.5 microM) and anal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42d0e09d6baeec9367ab372c9916dde0
https://doi.org/10.1158/1535-7163.22501207

Zobrazit plný text záznamu

Supplementary Table 1 from Effect of Niclosamide on Basal-like Breast Cancers

PDF file - 89KB, Supplementary Table S1. Sensitivity of BLBC cell lines to niclosamide mediated cytotoxicity. SUM159, HCC1187, HCC1143 and 2LMP BLBC NAAE and adherent cell lines were treated with niclosamide for 48 hours and analyzed for viability us

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a248301c09377c4d379a741b0c1f11fa
https://doi.org/10.1158/1535-7163.22501192

Zobrazit plný text záznamu

Supplementary Table 2 from Effect of Niclosamide on Basal-like Breast Cancers

PDF file - 72KB, Supplementary Table S2. Immunohistochemistry of mouse tumors treated for two weeks with vehicle control, niclosamide (20 mg/kg), TRA-8 (200 micro-g) or the combination of both agents. Tumors were stained and analyzed (H-score) for p-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a922eb4c4848d5ba030dc2c207f1b3c
https://doi.org/10.1158/1535-7163.22501189

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání